대한유방검진의학회

의료소식

home > 유방검진에 대해 > 의료소식

유방검진에 대해

New Mammogram Guidelines Spur Controversy(ACR Bulletin 09-11-18) By 관리자 / 2009-11-25 PM 03:56 / 조회 : 10882회
USPTF 발표에 관한 ACR의 입장은 어떨까? New Mammogram Guidelines Spur Controversy. In a story covered for the second consecutive day on each of the major networks, media reports noted that the new breast exam guidelines from the US Preventative Services Task Force sparked anger, skepticism, and confusion among women, physicians, and experts. The CBS Evening News (11/17, story 3, 1:50, Couric) reported that "new government guidelines for breast cancer screening" that "say routine mammograms are not necessary for most women in their 40s" are "upsetting many patients and their doctors." The US Preventative Services Task Force recommends that "women at low risk should not get screened until they're in their 50s and then every other year." NBC Nightly News (11/17, lead story, 5:20, Williams) reported that "a generation of American women has grown up believing that turning 40 means getting your first mammogram," and "a change that big, that sudden, isn't being taken lightly. Women are surprised, they're angry, they're skeptical. Some are scared they're going to miss something." The New York Times (11/18, A22, Steinhauer) reports that "there remains...confusion" among women who are "uneasy with the idea of shifting" their "own approach to breast cancer detection, based on new federal guidelines without first knowing the medical specifics behind them, and also what oncologists and breast cancer awareness groups were saying." Meanwhile, "major medical centers from across the country, including the Mayo Clinic and MD Anderson, are rejecting the new recommendations," ABC World News (11/17, lead story, 2:55, Gibson) reported. The guidelines, "which put the [panel] at odds with two major cancer organizations, came under immediate fire from some breast cancer specialists," McClatchy (11/17) reported. Both "the American Cancer Society and the National Cancer Institute said they had no plans to back down from their current" recommendations that "annual mammograms for women" start "at age 40." For its part, the American College of Radiology "said the recommendations could lead to 'countless unnecessary breast cancer deaths,'" the St. Louis Post-Dispatch (11/18, Bernhard) reports. Some physicians said "that they were simply not ready to make such a drastic change," the New York Times (11/18, A22, Belluck) reports. But, overall "most of the doctors...said they would inform younger women that the recommendations said they did not need mammograms if they were low-risk," while also pointing out to patients "that groups like the American Cancer Society and the American College of Obstetricians and Gynecologists are sticking to the earlier guidelines." The panel, however, is "not telling women don't get a mammogram until you're 50. They're just saying it's not a blanket statement that they have to get one at 40," the CBS Evening News (11/17, story 4, 2:00, Couric) reported, adding, "They're just saying it's not a blanket statement that they have to get one at 40." The panel is urging women to "discuss the pros and cons" with their physicians. But, experts note that the panel "had an absence of clinicians...that is, doctors that are working in the trenches, with breast cancer patients," ABC World News (11/17, story 2, 1:40, Gibson) reported. Some also argue that "it's wrong to equate saving lives with the angst caused by false positives" from mammography. The Newark Star-Ledger (11/18, Nutt), the Salt Lake Tribune (11/18, Rosetta), AFP (11/18), and MedPage Today (11/17, Bankhead) also covered the story. ACR Says New Mammogram Guidelines Would Reverse Decline In Breast Cancer Mortalities. Modern Healthcare (11/18, Rhea) reports, "The American College of Radiology has criticized a new set of breast-cancer screening recommendations from" the US Preventative Services Task Force that "suggest women ages 40 to 49 with no family history or predisposition for breast cancer no longer undergo routine mammography." The panel found that "while mammography screening reduced breast cancer rates by 15 percent in women ages 39 to 49, false-positive results and overdiagnosis of existing breast cancers were more likely to occur in women under 50." But, the ACR contends that the guidelines, published in the Annals of Internal Medicine, "were created without input from radiologists, and...would reverse a two-decade decline in breast cancer mortalities." Carol H. Lee, MD, chair of the ACR Breast Imaging Commission, noted that "if Medicare and private insurers adopt these incredibly flawed...recommendations as a rationale for refusing women coverage of these life-saving exams, it could have deadly effects for American women," ADVANCE for Imaging & Radiation Oncology (11/17) reported. James H. Thrall, MD, FACR, chair of ACR Board of Chancellors, was also "deeply concerned" that the guidelines would "jeopardize access to both long proven and cutting-edge diagnostic imaging technologies." HealthLeaders Media (11/17, Clark) also covered the story. Republicans Argue New Mammogram Guidelines Exemplify Healthcare Rationing. The Washington Post (11/18, Eggen, Stein) reports that the guidelines "plunge the nonpartisan, nonpolitical advisory panel into the middle of a strident Washington discussion about healthcare." Carol H. Lee, chair of the American College of Radiology's breast-imaging commission, said, "The only conclusion I can come to is it's economically motivated," given "this climate, when we are all paying attention to how we can decrease the cost of healthcare." In her column in the Washington Post (11/18), Kathleen Parker notes that "the timing of publication, in the midst of a healthcare reform debate about reducing medical costs, has eyebrows raised." The guidelines "sparked an outcry from those who say that the federal government is more interested in saving money than in improving women's health, even though the panel did not consider costs in its analysis," the Los Angeles Times (11/18, Levey) reports. In fact, "some Republicans jumped on the report as the kind of government intervention in medical decisions that Obama's healthcare plan would bring." Rep. Dave Camp (R-MI) noted, "This is what happens when bureaucrats make your healthcare decisions," the New York Times (11/17, Sack) "Prescriptions" blog reported. Republicans in Congress said "that the recommendation, with its analysis of the 'net benefit' of cancer screening, gave shape to fears that research into the effectiveness of medical procedures would be used to deny or ration care." From the American College of Radiology

New Mammogram Guidelines Spur Controversy(ACR Bulletin 09-11-18) By 관리자 / 2009-11-25 PM 03:56 / 조회 : 10882회

USPTF 발표에 관한 ACR의 입장은 어떨까?

New Mammogram Guidelines Spur Controversy.

In a story covered for the second consecutive day on each of the major networks, media reports noted that the new breast exam guidelines from the US Preventative Services Task Force sparked anger, skepticism, and confusion among women, physicians, and experts.

The CBS Evening News (11/17, story 3, 1:50, Couric) reported that "new government guidelines for breast cancer screening" that "say routine mammograms are not necessary for most women in their 40s" are "upsetting many patients and their doctors." The US Preventative Services Task Force recommends that "women at low risk should not get screened until they're in their 50s and then every other year."

NBC Nightly News (11/17, lead story, 5:20, Williams) reported that "a generation of American women has grown up believing that turning 40 means getting your first mammogram," and "a change that big, that sudden, isn't being taken lightly. Women are surprised, they're angry, they're skeptical. Some are scared they're going to miss something."

The New York Times (11/18, A22, Steinhauer) reports that "there remains...confusion" among women who are "uneasy with the idea of shifting" their "own approach to breast cancer detection, based on new federal guidelines without first knowing the medical specifics behind them, and also what oncologists and breast cancer awareness groups were saying."

Meanwhile, "major medical centers from across the country, including the Mayo Clinic and MD Anderson, are rejecting the new recommendations," ABC World News (11/17, lead story, 2:55, Gibson) reported. The guidelines, "which put the [panel] at odds with two major cancer organizations, came under immediate fire from some breast cancer specialists," McClatchy (11/17) reported. Both "the American Cancer Society and the National Cancer Institute said they had no plans to back down from their current" recommendations that "annual mammograms for women" start "at age 40." For its part, the American College of Radiology "said the recommendations could lead to 'countless unnecessary breast cancer deaths,'" the St. Louis Post-Dispatch (11/18, Bernhard) reports.

Some physicians said "that they were simply not ready to make such a drastic change," the New York Times (11/18, A22, Belluck) reports. But, overall "most of the doctors...said they would inform younger women that the recommendations said they did not need mammograms if they were low-risk," while also pointing out to patients "that groups like the American Cancer Society and the American College of Obstetricians and Gynecologists are sticking to the earlier guidelines."

The panel, however, is "not telling women don't get a mammogram until you're 50. They're just saying it's not a blanket statement that they have to get one at 40," the CBS Evening News (11/17, story 4, 2:00, Couric) reported, adding, "They're just saying it's not a blanket statement that they have to get one at 40." The panel is urging women to "discuss the pros and cons" with their physicians.

But, experts note that the panel "had an absence of clinicians...that is, doctors that are working in the trenches, with breast cancer patients," ABC World News (11/17, story 2, 1:40, Gibson) reported. Some also argue that "it's wrong to equate saving lives with the angst caused by false positives" from mammography. The Newark Star-Ledger (11/18, Nutt), the Salt Lake Tribune (11/18, Rosetta), AFP (11/18), and MedPage Today (11/17, Bankhead) also covered the story.

ACR Says New Mammogram Guidelines Would Reverse Decline In Breast Cancer Mortalities. Modern Healthcare (11/18, Rhea) reports, "The American College of Radiology has criticized a new set of breast-cancer screening recommendations from" the US Preventative Services Task Force that "suggest women ages 40 to 49 with no family history or predisposition for breast cancer no longer undergo routine mammography." The panel found that "while mammography screening reduced breast cancer rates by 15 percent in women ages 39 to 49, false-positive results and overdiagnosis of existing breast cancers were more likely to occur in women under 50." But, the ACR contends that the guidelines, published in the Annals of Internal Medicine, "were created without input from radiologists, and...would reverse a two-decade decline in breast cancer mortalities."

Carol H. Lee, MD, chair of the ACR Breast Imaging Commission, noted that "if Medicare and private insurers adopt these incredibly flawed...recommendations as a rationale for refusing women coverage of these life-saving exams, it could have deadly effects for American women," ADVANCE for Imaging & Radiation Oncology (11/17) reported. James H. Thrall, MD, FACR, chair of ACR Board of Chancellors, was also "deeply concerned" that the guidelines would "jeopardize access to both long proven and cutting-edge diagnostic imaging technologies." HealthLeaders Media (11/17, Clark) also covered the story.

Republicans Argue New Mammogram Guidelines Exemplify Healthcare Rationing. The Washington Post (11/18, Eggen, Stein) reports that the guidelines "plunge the nonpartisan, nonpolitical advisory panel into the middle of a strident Washington discussion about healthcare." Carol H. Lee, chair of the American College of Radiology's breast-imaging commission, said, "The only conclusion I can come to is it's economically motivated," given "this climate, when we are all paying attention to how we can decrease the cost of healthcare."

In her column in the Washington Post (11/18), Kathleen Parker notes that "the timing of publication, in the midst of a healthcare reform debate about reducing medical costs, has eyebrows raised." The guidelines "sparked an outcry from those who say that the federal government is more interested in saving money than in improving women's health, even though the panel did not consider costs in its analysis," the Los Angeles Times (11/18, Levey) reports. In fact, "some Republicans jumped on the report as the kind of government intervention in medical decisions that Obama's healthcare plan would bring."

Rep. Dave Camp (R-MI) noted, "This is what happens when bureaucrats make your healthcare decisions," the New York Times (11/17, Sack) "Prescriptions" blog reported. Republicans in Congress said "that the recommendation, with its analysis of the 'net benefit' of cancer screening, gave shape to fears that research into the effectiveness of medical procedures would be used to deny or ration care."

From the American College of Radiology

총 49개

번호	제목	작성자	조회수	작성일
49	40대 유방암 검진시 유방촬영술 필요	관리자	12722	2009-11-25
48	한국 여성들은 미(美)와 달라 40대부터 유방암 검진을	관리자	9176	2009-11-25
47	New Mammogram Guidelines Spur Controversy(ACR Bulletin 09-11-18)	관리자	10883	2009-11-25
46	유방촬영술, 미국 정부 제안처럼 50대로 바꿔야 할까? (RSNA Weekly 09-11-17)	관리자	6668	2009-11-25
45	유방촬영은 40대부터	관리자	12638	2004-10-30
44	남성은 전립선암, 여성은 유방암 급증 (조선일보 2월 21일)	관리자	7085	2004-10-30
43	[건강 핫뉴스] 수술전 초음파검사로 숨은 유방암 발견 (중앙일보 2월 18일)	관리자	6583	2004-10-30
42	자녀수·수유기간 유방암 발병과 반비례 <기사 제공: 메디칼트리뷴>	관리자	6519	2004-10-30
41	의학이 발전하면 인류는 행복해질까, 유방암 검진의 문제 [ 임호준 ]	관리자	5925	2004-10-30
40	국내 암환자 183명당 1명꼴 (한국일보 2002-11-13)	관리자	4031	2004-10-30

1 2 3 4 5